Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Arti Mahto et al.|The Lancet|2021Cited by 315
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trialFelice Rivellese, Raquel Celis, Anna E. A. Surace et al.|Nature Medicine|2022Cited by 277
BONE MARROW ASPIRATION AS A DIAGNOSTIC TOOL FOR ACUTE TOXOPLASMOSIS IN A KIDNEY TRANSPLANT RECIPIENTDOMINIQUE FERON, Joseph Wybran, Michel Goldman et al.|Transplantation|1990Cited by 9
Autologous stem cell transplantation in rheumatoid arthritisJohn A. Snowden, A Tyndall, John J. Moore et al.|eCite Digital Repository (University of Tasmania)|2001Cited by 5